@article{08c99c41722c4a7fb7c67c062e555b59,
title = "Treat \& extend in neovascular age-related macular degeneration: how we got here and where do we go next?",
keywords = "Humans, Angiogenesis Inhibitors/therapeutic use, Ranibizumab/therapeutic use, Macular Degeneration/drug therapy, Intravitreal Injections, Wet Macular Degeneration/drug therapy, Tomography, Optical Coherence, Treatment Outcome",
author = "\{Chair, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group\} and Varun Chaudhary and Mohit Bhandari and Wykoff, \{Charles C.\} and Sobha Sivaprasad and Lehana Thabane and Peter Kaiser and David Sarraf and Bakri, \{Sophie J.\} and Garg, \{Sunir J.\} and Singh, \{Rishi P.\} and Holz, \{Frank G.\} and Wong, \{Tien Y.\} and Guymer, \{Robyn H.\}",
year = "2023",
month = mar,
doi = "10.1038/s41433-022-02221-0",
language = "English (US)",
volume = "37",
pages = "581--583",
journal = "Eye (Basingstoke)",
issn = "0950-222X",
publisher = "Springer Nature",
number = "4",
}